| 翻訳と辞書 |
Pharmasset
Pharmasset Inc. is a pharmaceutical company based in Princeton, New Jersey in the United States. The company develops antiviral drugs for HIV (including racivir), hepatitis B (including clevudine, marketed as Levovir), and hepatitis C.〔"(Pharmasset Inc (VRUS:US) )." Bloomberg.〕 In November 2011, Pharmasset was acquired by Gilead for $11 billion.
==History==
Pharmasset was founded in 1998 by Raymond Schinazi and Dennis Liotta, scientists at Emory University. The company was initially incorporated in Barbados (as Pharmasset, Ltd.) and separately in Georgia. However, the company was redomiciled as a Delaware corporation on June 8, 2004.〔(Pharmasset Inc. Form 10-K ) (annual report filed 12/31/07 for the period ending 09/30/07).〕
Pharmasset's initial public offering took place on April 27, 2007, when it was first listed on NASDAQ.〔"(Pharmasset Announces Second Fiscal Quarter 2007 Financial Results )" (June 11, 2007) (press release). Pharmasset Inc.〕 The firm's stock return in the first three fiscal quarters (nine months) of 2011 was 278 percent. Among analysts, 17 rated the company's stock as "strong buy" or "buy," while two rated it a "hold." Pharmasset was the best performer in this period among all major U.S. exchanges among stocks trading for at least $1.50 on January 1, 2011.〔Brian Richards. "(With 9 Months Down, These Are the Best Stocks of 2011 )" (October 3, 2011). The Motley Fool.〕
抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』
■ウィキペディアで「Pharmasset」の詳細全文を読む
スポンサード リンク
| 翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|